Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2014 Apr 4:14:128.
doi: 10.1186/1471-2393-14-128.

Midtrimester preterm prelabour rupture of membranes (PPROM): expectant management or amnioinfusion for improving perinatal outcomes (PPROMEXIL - III trial)

Augustinus S P van Teeffelen  1 , David P van der Ham, Christine Willekes, Salwan Al Nasiry, Jan G Nijhuis, Sander van Kuijk, Ewoud Schuyt, Twan L M Mulder, Maureen T M Franssen, Dick Oepkes, Fenna A R Jansen, Mallory D Woiski, Mireille N Bekker, Caroline J Bax, Martina M Porath, Monique W M de Laat, Ben W Mol, Eva Pajkrt
Affiliations
Randomized Controlled Trial

Midtrimester preterm prelabour rupture of membranes (PPROM): expectant management or amnioinfusion for improving perinatal outcomes (PPROMEXIL - III trial)

Augustinus S P van Teeffelen et al. BMC Pregnancy Childbirth. .

Abstract

Background: Babies born after midtrimester preterm prelabour rupture of membranes (PPROM) are at risk to develop neonatal pulmonary hypoplasia. Perinatal mortality and morbidity after this complication is high. Oligohydramnios in the midtrimester following PPROM is considered to cause a delay in lung development. Repeated transabdominal amnioinfusion with the objective to alleviate oligohydramnios might prevent this complication and might improve neonatal outcome.

Methods/design: Women with PPROM and persisting oligohydramnios between 16 and 24 weeks gestational age will be asked to participate in a multi-centre randomised controlled trial.

Intervention: random allocation to (repeated) abdominal amnioinfusion (intervention) or expectant management (control). The primary outcome is perinatal mortality. Secondary outcomes are lethal pulmonary hypoplasia, non-lethal pulmonary hypoplasia, survival till discharge from NICU, neonatal mortality, chronic lung disease (CLD), number of days ventilatory support, necrotizing enterocolitis (NEC), periventricular leucomalacia (PVL) more than grade I, severe intraventricular hemorrhage (IVH) more than grade II, proven neonatal sepsis, gestational age at delivery, time to delivery, indication for delivery, successful amnioinfusion, placental abruption, cord prolapse, chorioamnionitis, fetal trauma due to puncture. The study will be evaluated according to intention to treat. To show a decrease in perinatal mortality from 70% to 35%, we need to randomise two groups of 28 women (two sided test, β-error 0.2 and α-error 0.05).

Discussion: This study will answer the question if (repeated) abdominal amnioinfusion after midtrimester PPROM with associated oligohydramnios improves perinatal survival and prevents pulmonary hypoplasia and other neonatal morbidities. Moreover, it will assess the risks associated with this procedure.

Trial registration: NTR3492 Dutch Trial Register (http://www.trialregister.nl).

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flowchart PPROMEXIL-III trial.
See this image and copyright information in PMC

References

    1. Kilbride HW, Thibeault DW. Neonatal complications of preterm rupture of membranes. Clin Perinatol. 2001;28(4):761–785. doi: 10.1016/S0095-5108(03)00076-9. - DOI - PubMed
    1. Sherer DM, Davis JM, Woods JR Jr. Pulmonary hypoplasia: a review. Obstetr Gynecol Surv. 1990;45(11):792–803. doi: 10.1097/00006254-199011000-00026. - DOI - PubMed
    1. Laudy JA, Wladimiroff JW. The fetal lung. 2: Pulmonary hypoplasia. Ultrasound Obstet Gynecol. 2000;16(5):482–494. doi: 10.1046/j.1469-0705.2000.00252.x. - DOI - PubMed
    1. Grisaru-Granovsky S, Eitan R, Kaplan M, Samueloff A. Expectant management of midtrimester premature rupture of membranes: a plea for limits. J Perinatol. 2003;23(3):235–239. doi: 10.1038/sj.jp.7210880. - DOI - PubMed
    1. Waters TP, Mercer BM. The management of preterm premature rupture of the membranes near the limit of fetal viability. Am J Obstet Gynecol. 2009;201(3):230–240. doi: 10.1016/j.ajog.2009.06.049. - DOI - PubMed

Publication types

MeSH terms

Associated data